PTC
DGX icon

Private Trust Company’s Quest Diagnostics DGX Stock Holding History

Private Trust Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
1,145
+6
+0.5% +$1.18K 0.02% 744
2026
Q1 		$223K Buy
1,139
+53
+5% +$10.3K 0.02% 726
2025
Q4 		$188K Sell
1,086
-93
-8% -$16.9K 0.02% 785
2025
Q3 		$225K Buy
1,179
+103
+10% +$18.3K 0.02% 712
2025
Q2 		$193K Buy
1,076
+23
+2% +$4K 0.02% 734
2025
Q1 		$178K Hold
1,053
– – 0.02% 748
2024
Q4 		$159K Buy
1,053
+75
+8% +$11.7K 0.02% 775
2024
Q3 		$152K Sell
978
-261
-21% -$39K 0.02% 788
2024
Q2 		$170K Hold
1,239
– – 0.02% 710
2024
Q1 		$165K Buy
1,239
+100
+9% +$13K 0.02% 713
2023
Q4 		$157K Buy
1,139
+757
+198% +$99.5K 0.02% 684
2023
Q3 		$46.6K Hold
382
– – 0.01% 1049
2023
Q2 		$53.7K Sell
382
-2,002
-84% -$276K 0.01% 1001
2023
Q1 		$337K Buy
2,384
+1,947
+446% +$279K 0.05% 402
2022
Q4 		$68K Sell
437
-54
-11% -$7.76K 0.01% 855
2022
Q3 		$60K Hold
491
– – 0.01% 830
2022
Q2 		$65K Buy
+491
New +$66.9K 0.01% 839
2014
Q4 		– Sell
-392
Closed -$24K – 504
2014
Q3 		$24K Sell
392
-10
-2% -$616 0.01% 781
2014
Q2 		$24K Buy
402
+53
+15% +$3.1K 0.01% 783
2014
Q1 		$20K Sell
349
-100
-22% -$5.36K 0.01% 728
2013
Q4 		$24K Hold
449
– – 0.01% 652
2013
Q3 		$28K Hold
449
– – 0.01% 570
2013
Q2 		$27K Buy
+449
New +$26.7K 0.01% 551

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Private Trust Company's DGX Position: Q2 2026 in Review

Private Trust Company increased its Quest Diagnostics (DGX) stake by 0.53% in Q2 2026, buying an estimated $1.18K and bringing the position to 1,145 shares worth $243K. The position accounts for 0.02% of the portfolio, ranked #744.

Private Trust Company first reported a position in DGX in Q2 2013 and has held it in 23 quarters since. The position peaked at $337K in Q1 2023. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Private Trust Company held 1,145 shares of Quest Diagnostics worth $243K as of Q2 2026.
  • Private Trust Company bought 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
  • Quest Diagnostics made up 0.02% of Private Trust Company's portfolio in Q2 2026, its #744 holding.
  • Private Trust Company first reported a position in Quest Diagnostics in Q2 2013 and has held it in 23 quarters since.
  • Private Trust Company's Quest Diagnostics position peaked at $337K in Q1 2023.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.